HuGE Literature Finder
|
||
Records 1-5
|
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer.
Science translational medicine 2018 04 10 (436): . Tanyi Janos L, Bobisse Sara, Ophir Eran, Tuyaerts Sandra, Roberti Annalisa, Genolet Raphael, Baumgartner Petra, Stevenson Brian J, Iseli Christian, Dangaj Denarda, Czerniecki Brian, Semilietof Aikaterini, Racle Julien, Michel Alexandra, Xenarios Ioannis, Chiang Cheryl, Monos Dimitri S, Torigian Drew A, Nisenbaum Harvey L, Michielin Olivier, June Carl H, Levine Bruce L, Powell Daniel J, Gfeller David, Mick Rosemarie, Dafni Urania, Zoete Vincent, Harari Alexandre, Coukos George, Kandalaft Lana |
|
An analysis of polymorphisms within the Wnt signaling pathway in relation to ovarian cancer risk in a Polish population.
Molecular diagnosis & therapy 2014 Feb 18 (1): 85-91. Mostowska Adrianna, Pawlik Piotr, Sajdak Stefan, Markowska Janina, Pawa?owska Monika, Lianeri Margarita, Jagodzinski Pawe? |
|
Assessment of hepatocyte growth factor in ovarian cancer mortality.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Aug 20 (8): 1638-48. Goode Ellen L, Chenevix-Trench Georgia, Hartmann Lynn C, Fridley Brooke L, Kalli Kimberly R, Vierkant Robert A, Larson Melissa C, White Kristin L, Keeney Gary L, Oberg Trynda N, Cunningham Julie M, Beesley Jonathan, Johnatty Sharon E, Chen Xiaoqing, Goodman Katelyn E, Armasu Sebastian M, Rider David N, Sicotte Hugues, Schmidt Michele M, Elliott Elaine A, Høgdall Estrid, Kjær Susanne Krüger, Fasching Peter A, Ekici Arif B, Lambrechts Diether, Despierre Evelyn, Høgdall Claus, Lundvall Lene, Karlan Beth Y, Gross Jenny, Brown Robert, Chien Jeremy, Duggan David J, Tsai Ya-Yu, Phelan Catherine M, Kelemen Linda E, Peethambaram Prema P, Schildkraut Joellen M, Shridhar Vijayalakshmi, Sutphen Rebecca, Couch Fergus J, Sellers Thomas A, |
|
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Dec 17 (12): 3567-72. Palmieri Rachel T, Wilson Melanie A, Iversen Edwin S, Clyde Merlise A, Calingaert Brian, Moorman Patricia G, Poole Charles, Anderson A Rebecca, Anderson Stephanie, Anton-Culver Hoda, Beesley Jonathan, Hogdall Estrid, Brewster Wendy, Carney Michael E, Chen Xiaoqing, Chenevix-Trench Georgia, Chang-Claude Jenny, Cunningham Julie M, Dicioccio Richard A, Doherty Jennifer A, Easton Douglas F, Edlund Christopher K, Gayther Simon A, Gentry-Maharaj Aleksandra, Goode Ellen L, Goodman Marc T, Kjaer Susanne Kruger, Hogdall Claus K, Hopkins Michael P, Jenison Eric L, Blaakaer Jan, Lurie Galina, McGuire Valerie, Menon Usha, Moysich Kirsten B, Ness Roberta B, Pearce Celeste Leigh, Pharoah Paul D P, Pike Malcolm C, Ramus Susan J, Rossing Mary Anne, Song Honglin, Terada Keith Y, Vandenberg David, Vierkant Robert A, Wang-Gohrke Shan, Webb Penelope M, Whittemore Alice S, Wu Anna H, Ziogas Argyrios, Berchuck Andrew, Schildkraut Joellen M, , , |
|
The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data.
Cancer 2001 Jul 92 (2): 440-5. Bahar AY, Taylor PJ, Andrews L, Proos A, Burnett L, Tucker K, Friedlander M, Buckley MF |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 31, 2019
- Content source: